Life Sciences Division

Square
Vistatec-Life-Sciences-Indentity-3

Life Sciences

at Vistatec

Translation and localization for essential medical services.

Life Sciences

at Vistatec

Translation and localization for essential medical services.

The Vistatec dedicated Life Sciences Division understands the importance of specialized workflows and expertise to deliver solutions for leading organizations worldwide. 

Our clients benefit from accurate and high-quality solutions, with industry-leading expertise demonstrated across a portfolio that includes medical devices, health care software, clinical trials, biotechnology, mental health, pharmaceuticals, and pure and applied science.

We provide multilingual support at every stage of the product life cycle.

Our Expertise

Life Sciences Industry

Where the world’s greatest minds are working simultaneously for the betterment of the human race.

Life Sciences Translation

Our life science localization experts are constantly adapting and evolving with the industry.

Additional Information

Additional ISO Certifications

ISO 9001:2015 Quality Management System | ISO 17100:2015 Translation Service Providers standards
ISO 27001:2013 Information Security | ISO 18587:2017 Machine translation post-editing

Life Sciences Experts

Kara Bolt

Director 
Life Sciences Division

Karen​ Tkaczyk, PhD

Director of Sales 
Life Sciences Division

Teresa Lawless

Development Director 
Life Sciences Division

Maria Mateos

Strategic Account Director
Life Sciences Division

Life Sciences Podcasts

Ep 0: Introduction Episode

Welcome to the introductory episode of the Life Sciences — In Focus podcast, brought to you by Vistatec. This podcast introduces a new avenue for exploring the dynamic and ever-evolving world of life sciences, with new episodes releasing regularly. 

Life Sciences Events

Life Sciences — In Focus

Leveraging Data and Trends for 2024

In the first installment of Vistatec’s Life Sciences – In Focus series, Amanda Murphy, Senior Director of Data Intelligence and Solutions at GlobalData, presented the biopharmaceutical industry’s outlook for 2024. The event yielded valuable insights into the trends and themes predicted for the upcoming year, focusing on the clinical trials landscape, including decentralized clinical trials and diversity. Click the video to watch the recording, or read the key learnings from the event here

Erin Nye, Illumina

Richard Korn, Edward Life Sciences

Sean Kinsell, Medidata